Mette Ilander

2PUBLICATIONS
26CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Aug 14, 2026
TIM3 blockade with hypomethylating therapy restores NK-cell and cytotoxic CD4+ T-cell activity in patients with AML or MDS.

|Feb 10, 2020
Age-associated changes in the immune system may influence the response to anti-PD1 therapy in metastatic melanoma patients.

Henna Kasanen, Micaela Hernberg, Siru Mäkelä

Pageof 1

Frequent Collaborators

2 joint publications

Satu Mustjoki

2 joint publications

Anna Kreutzman

1 joint publications

Henna Kasanen

1 joint publications

Micaela Hernberg

1 joint publications

Siru Mäkelä

1 joint publications

Laura Kohtamäki

1 joint publications

Jani Huuhtanen

1 joint publications

Sofia Forstén

1 joint publications

Brittany Ford

1 joint publications

Johannes Smolander

Frequent Collaborators

2 joint publications

Satu Mustjoki

2 joint publications

Anna Kreutzman

1 joint publications

Henna Kasanen

1 joint publications

Micaela Hernberg

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us